RSS

oncology

Tech start-up based in Cambridge, Repositive, has introduced new features to its Cancer Models Platform, in response to feedback from the growing user base, which it will present during the Tumor Models Conference in Boston, Massachusetts more

Technology

A new company that focuses on the development of oncology medicines in Asia, AUM Biosciences (AUM), has officially launched with millions in Singapore dollars of seed funding. more

News

Artelo Biosciences, a biopharmaceutical company, has entered into a global research and development partnership with India-based integrated discovery-development service provider, Syngene, and UK-based specialist CRO, Aptus Clinical. more

News

GlobalData has stated that according to its latest research immune-based gene therapy candidates should prevail in oncology, however, this novel approach is unchartered territory in oncology and will require new regulatory guidelines more

Analysis

IONTAS, a company focused on the discovery and optimisation of fully human antibodies, has signed a collaboration agreement with Korean-based LG Chem to identify therapeutic oncology leads. more

News

Ovarian cancer patients are losing out as funding and attention is focused on more prominent women’s diseases, says Australian oncology researcher, Dr Jim Coward, on World Ovarian Cancer Day (8 May). more

News

Swiss-based healthcare company, Novartis, has revealed that the US Food and Drug Administration (FDA) has approved its CAR-T therapy, Kymriah, for its second distinct indication. more

News

Company focused on the discovery and optimisation of fully human antibodies, IONTAS, and a private biopharmaceutical company, aTen Therapeutics, have announced a collaboration for the discovery of therapeutic oncology leads. more

News

Global drug discovery and development services company, Crown Bioscience, has been selected as a strategic partner by Phanes Therapeutics to accelerate the discovery and development of novel oncology agents. more

News

Roche has revealed it will acquire healthcare technology and services company, Flatiron Health, in an agreement that will see the companies leverage their respective expertise to advance industry-wide development and delivery of oncology medicines. more

News

Two CE-marked IVD liquid biopsy tests have been launched by molecular diagnostics company, Biocartis Group. — the Idylla ctKRAS Mutation Test and the Idylla ctNRAS-BRAF Mutation Test. more

Technology

Russian biotechnology company, BIOCAD, has revealed plans to enter the European market with oncological and autoimmune medicines. more

News

A retrospective cohort study has found no conclusive evidence that most oncology treatments approved for use by the EMA offered survival or quality of life benefits to patients, giving rise to calls for an increase in the evidence bar. more

News

An integrated oncology platform from Crown Bioscience has helped to advance the preclinical development of a HERA-GITRL immunotherapy from Apogenix for non-small cell lung cancer (NSCLC) and head and neck cancer. more

Technology

Following disappointing announcements this week concerning the unmet primary endpoints of their Phase III trials, Merck and AstraZeneca have today revealed they are entering a strategic oncology collaboration. more

News

The Lead Discovery Center (LDC), Max Planck Innovation and SOTIO have signed a collaboration and licence agreement providing SOTIO with exclusive rights to an oncology programme addressing a novel target in tumour metabolism. more

News

Scientists and staff from academic research institutes and the pharma industry will be able to be informed on the latest trends and challenges within the field of oncology at the Sartorius Research Xchange Forum 2017. more

News

Novartis has announced a strategic alliance and licensing agreement with Surface Oncology to grow its immune-oncology pipeline more

News

Sanofi is extending its existing collaboration with Warp Drive Bio to discover novel oncology therapeutics and antibiotics more

News

Array BioPharma and Pierre Fabre have announced a collaboration to globally develop and commercialise Array's late-stage novel oncology products, binimetinib and encorafenib more

News